12/14/22 – Caring for Colorado Youth
01/10/23 – Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)
01/10/23 – Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
02/14/23 – HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)
03/02/23 – Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
03/15/23 – Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
Both programs offer a unique opportunity for internal mock grant review for those submitting NIH grant applications. Participants will receive specific written and verbal critiques of their proposals prior to submission to the funding agency.
The Steven Fadul Award is an annual prize of $1,500, awarded to an outstanding PRA or other member of the School's technical research staff.
Nominations for the 2022 Steven Fadul Award are being accepted now through November 16, 2022.
Biomedical research increasingly relies on teamwork among students, postdocs, faculty, and PRAs and other members of our technical staff. Of these, it is the technical staff who, over a period of years, log the most time in the lab and acquire unique knowledge, insight, and wisdom. They become the foundation for an efficient, productive, and collegial research atmosphere. Their contributions, however, are not recognized to the extent that they deserve. We seek to reward them, and in doing so to honor Steve Fadul's memory and strengthen the research enterprise at the School of Medicine.
Questions regarding this award and the process can be emailed to the Department of Physiology and Biophysics or call (303) 724-4500.
We are now recruiting Scholars for the University of Colorado School of Medicine Fund to Retain Clinical Scientists (CU-FRCS).
The Colorado Diabetes Research Center Pilot & Feasibility Program funds diabetes researchers distributed across spectrum of basic science, translational, clinical and health disparities research who investigate T1D, T2D, and/or diabetes complications and is a key element in recruiting and training promising diabetes research scientists.
Applications will be considered from both junior and established investigators.
The N3C PHASTR initiative is a new opportunity to use N3C data to provide fast actionable analyses on high-impact COVID-19 public health questions. It’s also an opportunity to increase community engagement on using big data for research and machine learning best practices.
Each award is for 1 year in the amount of $70,000. Application Due Date: Friday, December 2nd, 2022.
The purpose of this grant program is to support the development of exceptional research projects that will help lead to the conquest of cancer and will further the objectives of the CU Cancer Center. Studies in all areas of cancer research - laboratory, clinical, prevention and control, and psychosocial cancer research - will be considered for funding.
ACS IRG Grants aim to entice young faculty to pursue cancer-related research problems and are reserved for applicants who are in their first few years as junior faculty members (instructors and assistant professors) and who are in the process of establishing independent cancer research programs.
Questions regarding the ACS-IRG seed grants and application should be directed to Paige Diller. All applications should be submitted online. Please note, paper applications will not be accepted or reviewed.
High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT) is now available in the outpatient Adult CTRC to obtain non-invasive 3D images at the distal tibia and distal radius of humans for clinical in vivo assessments of volumetric bone mineral density and parameters of bone quality (e.g., microarchitecture, geometry, porosity, and biomechanics). XtremeCT II HR-pQCT scanner images have a very small isotropic voxel size (60.7 μm) and very low radiation dose (≤5 μSv per scan/anatomical site) so the device can be used for studies performed in adult, adolescent, and pediatric populations.
These seed grants are intended to increase utilization of this new instrument and can only be used for HR-pQCT scanning/analysis. They are supported by the CCTSI, the Vice Chancellor of Research, and Pediatric Endocrinology at Children’s Hospital Colorado.
Applications are due February 15, 2023.
This course gives an introduction to statistical thinking and communication involving basic statistical models and tests and is appropriate for those familiar with biomedical research but little or no statistical expertise. Fall 2022, the course is offered November thru December from 6-8pm.
For questions email Luan Nguyen at the Center for Innovative Design and Analysis.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.